Skip to main content

Table 1 Demographic characteristics and comorbidities of patients with newly diagnosed PKD in Taiwan during 2000–2012

From: Increased risk of pulmonary and extrapulmonary tuberculosis infection in patients with polycystic kidney disease: a nationwide population-based study with propensity score-matching analysis

Variable

PKD

p-value

Total

No

Yes

N = 13,540

n = 6770

n = 6770

n

n (%) / mean ± SD

n (%) / mean ± SD

Gender

   

0.81

 Female

5660

2823 (41.7)

2837 (41.9)

 

 Male

7880

3947 (58.3)

3933 (58.1)

 

Age at baseline

   

0.99

 20–34

1164

583 (8.6)

581 (8.6)

 

 35–49

3168

1580 (23.3)

1588 (23.5)

 

 50–64

3903

1945 (28.7)

1958 (28.9)

 

 > 65

5305

2662 (39.3)

2643 (39)

 

 Age, mean(SD)

 

59.1 (16.8)

59.1 (16.8)

0.99

Comorbidity

 Hypertension

4509

2266 (33.5)

2243 (33.1)

0.67

 Hyperlipidemia

742

381 (5.6)

361 (5.3)

0.45

 Alcohol related disease

161

87 (1.3)

74 (1.1)

0.30

 Chronic kidney disease

2853

1427 (21.1)

1426 (21.1)

0.98

 ESRD

1437

714 (10.5)

723 (10.7)

0.80

 Chronic liver disease

885

454 (6.7)

431 (6.4)

0.42

 COPD

801

396 (5.8)

405 (6)

0.74

 Diabetes

1263

644 (9.5)

619 (9.1)

0.46

 Bacterial infection

3327

1644 (24.3)

1683 (24.9)

0.44

 Viral infection

1011

526 (7.8)

485 (7.2)

0.18

 Pneumoconiosis

171

90 (1.3)

81 (1.2)

0.49

  1. COPD chronic obstructive pulmonary disease
  2. Chi-square test, t-test